Discovery of a gene that could be key for reducing breast cancer risk

by University of OtagoCharacterization of SULT1A1. a Genomic viewer (UCSC) of the SULT1A1 gene locus with copy number variants; deletion (red) and duplication (blue). b Dosage effect in breast tu

Updated on: January 30,2024 16

Discovery of a gene that could be key for reducing breast cancer risk

by University of OtagoCharacterization of SULT1A1. a Genomic viewer (UCSC) of the SULT1A1 gene locus with copy number variants; deletion (red) and duplication (blue). b Dosage effect in breast tu

Updated on:January 30,2024 16

The role of 'extra' DNA in cancer evolution and therapy resistance

by Sarah Laskowski,Henry Ford Health SystemCredit: Henry Ford Health SystemGlioblastoma (GBM) is the most common and aggressive form of brain cancer. Response to standard-of-care treatment is po

Updated on: March 13,2024 15

The role of 'extra' DNA in cancer evolution and therapy resistance

by Sarah Laskowski,Henry Ford Health SystemCredit: Henry Ford Health SystemGlioblastoma (GBM) is the most common and aggressive form of brain cancer. Response to standard-of-care treatment is po

Updated on:March 13,2024 15

Neoantigen DNA Vaccines: A Promising Approach for Triple Negative Breast Cancer

Among innovative strategies, neoantigen DNA vaccines have emerged as a particularly promising approach, offering hope for improved patient outcomes.

Updated on: November 15,2024 0

Neoantigen DNA Vaccines: A Promising Approach for Triple Negative Breast Cancer

Among innovative strategies, neoantigen DNA vaccines have emerged as a particularly promising approach, offering hope for improved patient outcomes.

Updated on:November 15,2024 0

Cervical cancer discovery offers major new clue to better understand the disease

byUniversity College LondonDifferences in the tumor microenvironment between cervical cancer subgroups. Plot showing median abundances (x-axis) and median differences (%, y-axis) for different c

Updated on: January 22,2024 11

Cervical cancer discovery offers major new clue to better understand the disease

byUniversity College LondonDifferences in the tumor microenvironment between cervical cancer subgroups. Plot showing median abundances (x-axis) and median differences (%, y-axis) for different c

Updated on:January 22,2024 11

Researchers map DNA damage links to onset of skin cancer, melanoma

by Washington State UniversityDNA damage resulting in multiple broken chromosomes. Credit: Wikipedia/CC BY-SA 3.0A critical link in mapping recurrent mutations of melanoma—the most serious form o

Updated on: March 12,2024 12

Researchers map DNA damage links to onset of skin cancer, melanoma

by Washington State UniversityDNA damage resulting in multiple broken chromosomes. Credit: Wikipedia/CC BY-SA 3.0A critical link in mapping recurrent mutations of melanoma—the most serious form o

Updated on:March 12,2024 12

Researchers develop AI-based tool paving the way for personalized cancer treatments

byArizona State UniversityAnalyzing nearly 6,000 MHC-1 complexes, the research team discovered patterns that can identify these preferences and predict immune responses across a broad range of h

Updated on: March 30,2024 0

Researchers develop AI-based tool paving the way for personalized cancer treatments

byArizona State UniversityAnalyzing nearly 6,000 MHC-1 complexes, the research team discovered patterns that can identify these preferences and predict immune responses across a broad range of h

Updated on:March 30,2024 0

Pharmacoscopy improves therapy for relapsed blood cancer in a first clinical trial

by CeMM Research Center for Molecular Medicine of the Austrian Academy of SciencesPatient cells imaged by pharmacoscopy. Credit: CeMM/Gregory VladimerResearchers at CeMM and the Medical University of

Updated on: April 22,2024 11

Pharmacoscopy improves therapy for relapsed blood cancer in a first clinical trial

by CeMM Research Center for Molecular Medicine of the Austrian Academy of SciencesPatient cells imaged by pharmacoscopy. Credit: CeMM/Gregory VladimerResearchers at CeMM and the Medical University of

Updated on:April 22,2024 11

Breakthrough brings potential glioblastoma drug into focus

byKeck School of Medicine of USCA new type of small molecule drug, the first to target circadian clock proteins as a way to treat glioblastoma, is now in phase 1 clinical trials. Credit: Issey T

Updated on: January 07,2024 10

Breakthrough brings potential glioblastoma drug into focus

byKeck School of Medicine of USCA new type of small molecule drug, the first to target circadian clock proteins as a way to treat glioblastoma, is now in phase 1 clinical trials. Credit: Issey T

Updated on:January 07,2024 10

Women with benign breast disease face higher risk of breast cancer in the long term, according to large-scale study

by European Organisation for Research and Treatment of CancerCumulative incidence rates of breast cancer and 95% confidence intervals in women with and without benign breast disease within year at ind

Updated on: February 03,2024 10

Women with benign breast disease face higher risk of breast cancer in the long term, according to large-scale study

by European Organisation for Research and Treatment of CancerCumulative incidence rates of breast cancer and 95% confidence intervals in women with and without benign breast disease within year at ind

Updated on:February 03,2024 10

Overall cancer mortality continues to decline

by National Cancer InstituteCredit: CC0 Public DomainThe latest Annual Report to the Nation on the Status of Cancer finds that, for all cancer sites combined, cancer death rates continued to decl

Updated on: April 01,2024 20

Overall cancer mortality continues to decline

by National Cancer InstituteCredit: CC0 Public DomainThe latest Annual Report to the Nation on the Status of Cancer finds that, for all cancer sites combined, cancer death rates continued to decl

Updated on:April 01,2024 20

New therapy could help chronic myeloid leukemia patients live drug-free

by South Australian Health and Medical Research Institute (SAHMRI)Credit: AI-generated imageThe latest research from SAHMRI and the University of Adelaide has discovered a potential new therapy for ch

Updated on: January 13,2024 17

New therapy could help chronic myeloid leukemia patients live drug-free

by South Australian Health and Medical Research Institute (SAHMRI)Credit: AI-generated imageThe latest research from SAHMRI and the University of Adelaide has discovered a potential new therapy for ch

Updated on:January 13,2024 17

The tumor environment can affect breast cancer prognosis

byLund UniversityFlowchart of included and excluded patients and representative pictures of each CAV1 staining category in stroma and cytoplasm. Credit:Translational Oncology(2022).

Updated on: January 22,2024 20

The tumor environment can affect breast cancer prognosis

byLund UniversityFlowchart of included and excluded patients and representative pictures of each CAV1 staining category in stroma and cytoplasm. Credit:Translational Oncology(2022).

Updated on:January 22,2024 20